CN103736014B - A kind of Chinese medicine composition for the treatment of hyperplasia of prostate - Google Patents
A kind of Chinese medicine composition for the treatment of hyperplasia of prostate Download PDFInfo
- Publication number
- CN103736014B CN103736014B CN201310742679.7A CN201310742679A CN103736014B CN 103736014 B CN103736014 B CN 103736014B CN 201310742679 A CN201310742679 A CN 201310742679A CN 103736014 B CN103736014 B CN 103736014B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese medicine
- hyperplasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese medicine composition for the treatment of hyperplasia of prostate, be made up of according to weight fraction following component: Radix Et Caulis Acanthopanacis Senticosi 30-40 part, Radix Morindae Officinalis 30-40 part, Ootheca Mantidis 30-40 part, Placenta Hominis 30-40 part, Rhizoma Dioscoreae 30-40 part, Semen Vaccariae 20-30 part, Rhizoma Atractylodis Macrocephalae 20-30 part, Folium Bambusae 20-30 part, Herba Houttuyniae 20-30 part, Radix Boehmeriae 20-30 part, Radix Rubiae 10-20 part, Rhizoma Curcumae 10-20 part, Rhizoma Corydalis 10-20 part, Herba Leonuri 10-20 part.The Chinese medicine composition for the treatment of hyperplasia of prostate of the present invention, formulated according to theory of Chinese medical science, QI invigorating, kidney invigorating and YANG supporting, stimulate the menstrual flow, diuresis, invigorate blood circulation, circulation of qi promoting, Chinese medicine preparation, toxic and side effects is little, and cost is low, treating both the principal and secondary aspects of a disease.
Description
Technical field
The present invention relates to field of traditional Chinese, particularly a kind of Chinese medicine composition for the treatment of hyperplasia of prostate.
Background technology
Prostatic hyperplasia (BPH) is one of male senile patient common disease, cumulative many with population in the world senescence onset of illness.The sickness rate of prostatic hyperplasia increased progressively with the age, but not necessarily had clinical symptoms when having preneoplastic lesions.
Hyperplasia of prostate is relevant with the traditional Chinese medical science " difficulty in urination ".The name of " difficulty in urination ", first sees Huangdi's Internal Classics.As " Huang di's Canon of Medicine Ling Shu Miraculous Pivot or Divine Axis is originally defeated " section is said: " difficulty in urination, void is incontinence of urine then." " Huang di's Canon of Medicine Plain Questions declares five gas sections " also say: " bladder discord, for infirmity, is not about incontinence of urine." traditional Chinese medical science thinks, worn with age, kidney qi virtual loss is the pathogenesis basis of primary disease, and it is basic pathological factor that blood stasis loses essence, and excessive fatigue, emotional stimulation, diseases caused by exogenous pathogenic factor six climate exopathogens, eating and drinking without temperance are common onset conditions, and deficiency in origin and excess in superficiality is the basic pathogenesis feature of primary disease.Only both hyperplasia of prostate and the difficulty in urination, the former says with its pathological change, and the latter says with its dysuria, and the angle of name is different.
The medicine of existing this type of disease for the treatment of is a lot, the conventional medicine such as general employing " QIANLIEKANG ", " QIANLIETONG JIAONANG ", although these conventional medicines have certain therapeutic effect, existence is cured the symptoms, not the disease, curative effect is slow, the course for the treatment of is long, cure rate is low and the shortcoming of easily recurrence.Doctor trained in Western medicine then more adopts modern so-called high-tech laser surgery therapy, and this is a kind of invasive treatment, can cause infection, brings unnecessary trouble to patient.
Summary of the invention
For the defect existed in prior art, the object of the present invention is to provide a kind of Chinese medicine composition for the treatment of hyperplasia of prostate.
Technical scheme of the present invention is as follows:
Treat a Chinese medicine composition for hyperplasia of prostate, be made up of according to weight fraction following component:
Radix Et Caulis Acanthopanacis Senticosi 30-40 part, Radix Morindae Officinalis 30-40 part, Ootheca Mantidis 30-40 part, Placenta Hominis 30-40 part, Rhizoma Dioscoreae 30-40 part, Semen Vaccariae 20-30 part, Rhizoma Atractylodis Macrocephalae 20-30 part, Folium Bambusae 20-30 part, Herba Houttuyniae 20-30 part, Radix Boehmeriae 20-30 part, Radix Rubiae 10-20 part, Rhizoma Curcumae 10-20 part, Rhizoma Corydalis 10-20 part, Herba Leonuri 10-20 part.
On the basis of such scheme, a kind of Chinese medicine composition for the treatment of hyperplasia of prostate, is made up of according to weight fraction following component:
Radix Et Caulis Acanthopanacis Senticosi 35 parts, Radix Morindae Officinalis 35 parts, Ootheca Mantidis 35 parts, Placenta Hominis 35 parts, Rhizoma Dioscoreae 35 parts, Semen Vaccariae 25 parts, the Rhizoma Atractylodis Macrocephalae 25 parts, 25 parts, Folium Bambusae, Herba Houttuyniae 25 parts, Radix Boehmeriae 25 parts, 15 parts, Radix Rubiae, Rhizoma Curcumae 15 parts, Rhizoma Corydalis 15 parts, Herba Leonuri 15 parts.
Chinese medicine composition of the present invention, reasonable recipe, in prescription: Radix Et Caulis Acanthopanacis Senticosi replenishing QI to invigorate the spleen, tonifying the kidney for tranquilization, Radix Morindae Officinalis reinforcing the kidney and supporting YANG, Ootheca Mantidis reinforcing the kidney and supporting YANG, controlling nocturnal emission with astringent drugs reducing urination, Placenta Hominis mend essence, nourish blood, QI invigorating, Rhizoma Dioscoreae supplementing QI and nourishing YIN, Chinese medicine of the five flavours is monarch drug altogether; Semen Vaccariae is invigorated blood circulation, stimulate the menstrual flow, Rhizoma Atractylodis Macrocephalae air making-up and spleen enlivening, dampness diuretic, Folium Bambusae diuresis, promotes the production of body fluid, Herba Houttuyniae heat-clearing and toxic substances removing, inducing diuresis for treating stranguria syndrome, Radix Boehmeriae diuresis, removing toxic substances, and Chinese medicine of the five flavours is ministerial drug altogether; Radix Rubiae cooling blood for hemostasis, blood circulation promoting and blood stasis dispelling, Rhizoma Curcumae promoting the circulation of QI to relieve pain, removing blood stasis, Rhizoma Corydalis blood-activating and qi-promoting, pain relieving, Herba Leonuri blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, heat-clearing and toxic substances removing, four taste Chinese medicines are adjuvant drug altogether; 14 taste Chinese medicines share, play QI invigorating, kidney invigorating and YANG supporting altogether, stimulate the menstrual flow, diuresis, invigorate blood circulation, effect of circulation of qi promoting, effectively treat hyperplasia of prostate.
The Chinese medicine composition for the treatment of hyperplasia of prostate of the present invention, formulated according to theory of Chinese medical science, QI invigorating, kidney invigorating and YANG supporting, stimulate the menstrual flow, diuresis, invigorate blood circulation, circulation of qi promoting, Chinese medicine preparation, toxic and side effects is little, and cost is low, treating both the principal and secondary aspects of a disease.
Detailed description of the invention
Embodiment 1
Treat a Chinese medicine composition for hyperplasia of prostate, be made up of (every part of 1g) according to weight fraction following component:
Radix Et Caulis Acanthopanacis Senticosi 30 parts, Radix Morindae Officinalis 30 parts, Ootheca Mantidis 30 parts, Placenta Hominis 30 parts, Rhizoma Dioscoreae 30 parts, Semen Vaccariae 20 parts, the Rhizoma Atractylodis Macrocephalae 20 parts, 20 parts, Folium Bambusae, Herba Houttuyniae 20 parts, Radix Boehmeriae 20 parts, 10 parts, Radix Rubiae, Rhizoma Curcumae 10 parts, Rhizoma Corydalis 10 parts, Herba Leonuri 10 parts.
Embodiment 2
Treat a Chinese medicine composition for hyperplasia of prostate, be made up of (every part of 1g) according to weight fraction following component:
Radix Et Caulis Acanthopanacis Senticosi 35 parts, Radix Morindae Officinalis 35 parts, Ootheca Mantidis 35 parts, Placenta Hominis 35 parts, Rhizoma Dioscoreae 35 parts, Semen Vaccariae 25 parts, the Rhizoma Atractylodis Macrocephalae 25 parts, 25 parts, Folium Bambusae, Herba Houttuyniae 25 parts, Radix Boehmeriae 25 parts, 15 parts, Radix Rubiae, Rhizoma Curcumae 15 parts, Rhizoma Corydalis 15 parts, Herba Leonuri 15 parts.
Embodiment 3
Treat a Chinese medicine composition for hyperplasia of prostate, be made up of (every part of 1g) according to weight fraction following component:
Radix Et Caulis Acanthopanacis Senticosi 40 parts, Radix Morindae Officinalis 40 parts, Ootheca Mantidis 40 parts, Placenta Hominis 40 parts, Rhizoma Dioscoreae 40 parts, Semen Vaccariae 30 parts, the Rhizoma Atractylodis Macrocephalae 30 parts, 30 parts, Folium Bambusae, Herba Houttuyniae 30 parts, Radix Boehmeriae 30 parts, 20 parts, Radix Rubiae, Rhizoma Curcumae 20 parts, Rhizoma Corydalis 20 parts, Herba Leonuri 20 parts.
Experimental example:
The prescription that the present invention treats hyperplasia of prostate makes decoction traditionally, every day potion, every day twice 30 days is a course for the treatment of, takes 3 courses for the treatment of continuously.
The present invention chooses 80 routine benign prostatic hyperplasia patientss altogether.In 80 routine patients, minimum 40 years old of age, maximum 85 years old, 54 years old mean age, the course of disease 3 ~ 10 years.
Curative effect judging standard is:
Cure: after treatment, pudendum discomfort, pain, burning sensation, semen in urine, seminal emission and the transference cure such as frequent micturition, dysuria, do not affect sleep and orthobiosis.Without recurrence in 3 years.
Take a turn for the better: after treatment, pudendum discomfort, pain, burning sensation, semen in urine, seminal emission and the symptom such as frequent micturition, dysuria, obviously alleviate and take a turn for the better.
Invalid: after treatment, pudendum discomfort, pain, burning sensation, semen in urine, seminal emission and the symptom such as frequent micturition, dysuria, be not improved or increase the weight of.
80 routine patients take the medicine of embodiment 2, after the treatment of 3 courses for the treatment of, cure 68 examples, and take a turn for the better 12 examples, invalid 0 example.
Claims (2)
1. treat a Chinese medicine composition for hyperplasia of prostate, it is characterized in that being made up of according to parts by weight following component:
Radix Et Caulis Acanthopanacis Senticosi 30-40 part, Radix Morindae Officinalis 30-40 part, Ootheca Mantidis 30-40 part, Placenta Hominis 30-40 part, Rhizoma Dioscoreae 30-40 part, Semen Vaccariae 20-30 part, Rhizoma Atractylodis Macrocephalae 20-30 part, Folium Bambusae 20-30 part, Herba Houttuyniae 20-30 part, Radix Boehmeriae 20-30 part, Radix Rubiae 10-20 part, Rhizoma Curcumae 10-20 part, Rhizoma Corydalis 10-20 part, Herba Leonuri 10-20 part.
2. the Chinese medicine composition for the treatment of hyperplasia of prostate according to claim 1, is characterized in that being made up of according to parts by weight following component:
Radix Et Caulis Acanthopanacis Senticosi 35 parts, Radix Morindae Officinalis 35 parts, Ootheca Mantidis 35 parts, Placenta Hominis 35 parts, Rhizoma Dioscoreae 35 parts, Semen Vaccariae 25 parts, the Rhizoma Atractylodis Macrocephalae 25 parts, 25 parts, Folium Bambusae, Herba Houttuyniae 25 parts, Radix Boehmeriae 25 parts, 15 parts, Radix Rubiae, Rhizoma Curcumae 15 parts, Rhizoma Corydalis 15 parts, Herba Leonuri 15 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310742679.7A CN103736014B (en) | 2013-12-27 | 2013-12-27 | A kind of Chinese medicine composition for the treatment of hyperplasia of prostate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310742679.7A CN103736014B (en) | 2013-12-27 | 2013-12-27 | A kind of Chinese medicine composition for the treatment of hyperplasia of prostate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103736014A CN103736014A (en) | 2014-04-23 |
| CN103736014B true CN103736014B (en) | 2016-03-30 |
Family
ID=50493130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310742679.7A Expired - Fee Related CN103736014B (en) | 2013-12-27 | 2013-12-27 | A kind of Chinese medicine composition for the treatment of hyperplasia of prostate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103736014B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103721193A (en) * | 2014-01-02 | 2014-04-16 | 张永雷 | Traditional Chinese medicine composition for treating prostate hyperplasia |
| CN105902847A (en) * | 2016-04-24 | 2016-08-31 | 邹洪胜 | Traditional Chinese medicinal composition for treating prostatoplasia |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732660A (en) * | 2009-12-25 | 2010-06-16 | 卢速江 | Chinese medicinal preparation for treating prostate disease and preparation method thereof |
-
2013
- 2013-12-27 CN CN201310742679.7A patent/CN103736014B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732660A (en) * | 2009-12-25 | 2010-06-16 | 卢速江 | Chinese medicinal preparation for treating prostate disease and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 中医药治疗前列腺增生症的临床研究概况;詹慧春等;《实用中西医结合临床》;20030228;第3卷(第1期);59-61 * |
| 中药复方治疗前列腺增生症概况;黄飞等;《中医杂志》;20071231;第48卷(第9期);852-854 * |
| 前列腺增生症中医药治疗概述;韦景春;《实用中医内科杂志》;19991231;第13卷(第1期);1-4 * |
| 王久源教授从脏腑论治前列腺增生;于月书等;《河南中医》;20080731;第28卷(第7期);30-31 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103736014A (en) | 2014-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN102114217B (en) | Traditional Chinese medicine fumigant for treating tinea capitis | |
| CN102631512B (en) | Traditional Chinese medicine composition for curing chronic colitis | |
| CN103736014B (en) | A kind of Chinese medicine composition for the treatment of hyperplasia of prostate | |
| CN105412456A (en) | Traditional Chinese plaster for treating dysmenorrhea | |
| CN108210551A (en) | A kind of Chinese medicine composition and its preparation method and application and application process | |
| CN100546640C (en) | A kind of Chinese medicine composition of orally taken for curing cyclomastopathy | |
| CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
| CN103041085B (en) | Traditional Chinese medicine composition for treating dysmenorrheal by lavipeditum nursing and application | |
| CN101028503B (en) | Oral Chinese-medicine composition for treating Raynaud's disease | |
| CN104258352A (en) | Traditional Chinese medicine composition for treating sterility caused by uterus cold through medicine-separated moxibustion | |
| CN104398949A (en) | Traditional Chinese medicine oral liquid for treating prostatitis | |
| CN103908509B (en) | Treatment chloasma, fat external umbilical treatment patch | |
| CN103768214B (en) | A kind of Chinese medicine composition for the treatment of kidney yang deficiency syndrome rhinitis | |
| CN103721193A (en) | Traditional Chinese medicine composition for treating prostate hyperplasia | |
| CN103263645B (en) | Gastritis and gastric ulcer treatment drug | |
| CN106511574A (en) | Traditional Chinese medicine externally applied plaster for treating wind-cold-dampness syndrome cervical spondylosis | |
| CN102198201B (en) | Traditional Chinese medicine composition for treating deficiency-cold headache | |
| CN103948804B (en) | A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale | |
| CN105853833A (en) | Traditional Chinese medicine wine for treating tinnitus and preparation method thereof | |
| CN105477067A (en) | Traditional Chinese medicine composition for treating dampness obstructing spleen-stomach type infantile jaundice | |
| CN105521391A (en) | Traditional Chinese medicine for tonifying liver and kidney and for strengthening bones and muscles and preparation method of traditional Chinese medicine | |
| CN104997949A (en) | Traditional Chinese medicine for treating rhinitis and preparation method thereof | |
| CN104840654A (en) | Traditional Chinese medicinal liquor for treating ischialgia | |
| CN101439110B (en) | Chinese medicine for curing rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160330 Termination date: 20161227 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |